Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
1(100.0%)
1Total
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT01946919Completed

Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study

Role: collaborator

NCT04451967Unknown

Acute Myocardial Infarction Study in Northeastern China

Role: collaborator

NCT02215642Unknown

Nutrition and Lifestyle Study Cohort of Colorectal Cancer in China

Role: collaborator

NCT02216955Unknown

Nutrition and Lifestyle Study Cohort of Gastric Cancer in China

Role: collaborator

NCT01196260Phase 2Unknown

Combination Chemotherapy Treatments in Patients With Colorectal Cancer Stage II and III

Role: collaborator

NCT02637661Unknown

Earlobe Crease as Risk Factors of Acute Myocardial Infarction in Chinese Population

Role: collaborator

All 6 trials loaded